The active ingredient in medical marijuana referred to as 9 tetrahydrocannabinol or THC is presently being investigated for its different uses in several clinical studies. Among the most recent effects of THC that is currently being studied is its capability to inhibit the growth of tumors which discovery might have far reaching consequences on the research connected with the management of cancer. The findings of a research study conducted by Salazar et al. which have been published in the Journal of Clinical Investigation indicate that THC found in medical hash oil triggers the autophagy of tumor cells.

Autophagy refers to the process of cell degradation where the cells start destroying themselves. MMJ is known to inhibit tumor growth by activating a series of events within cancer cells that triggers their death in a programmed manner (also generally known as apoptosis). Medical cannabis has a number of useful cannabinoids and other components and their capability to produce certain physiological changes can also be being investigated. Hash oil that's loaded with these useful and interesting cannabinoids like 9 THC and other may hold the answer cbd rub for pain the management of cancer as suggested by researchers in Spain who published their findings within the British Journal of Cancer.

Their study was primarily geared toward treating prostate cancer and the results clearly established that this group of molecules that will be originally found in cannabis might be a potential solution. 9 THC isn't going to kill the cancer cells ravenously and with virtually no discrimination. Actually, the process of cell death will be extremely targeted and highly specific as THC adopts a cell surface receptor binding mechanism that activates a cell signaling pathway, thereby triggering cell death. As these changes are brought about at the cellular level with various molecular players and factors coming into play, scientists were able to use knockout mice and siRNA to learn how the entire process works. Aside from being orderly and autophagy being one of the most important steps contributing to this process of programmed cell death, the beneficial biological effects of cannabinoids in coping with symptoms of other chronic ailments and diseases is additionally in progress.

Medical marijuana not just slows the spread and growth of cancer, but additionally, it kills them and its use in the prevention and treatment of bowel cancer is well documented. Professor Chris Paraskeva in Bristol whose work is funded by Cancer Research UK is investigating the anti-cancer properties of cannabinoids for the management of this sort of cancer. All of the studies have been executed using purified cannabinoid chemicals and not cannabis itself that contains a number of other chemicals. At the same, time, there is no reliable evidence which shows that smoking MMJ can treat cancer.

You will discover mainly two types of cannabinoid receptors; CB1 and CB2 that trigger the cascade of biological events within them. While the former type is mainly found within the nerve cells of the brain and is responsible for the mind altering effects of cannabis, the second is found all over the body and it may very well be the prime suspect that triggers the biological effects of these cannabinoids on another parts of the human body apart from the brain. So, designing suitable drugs in accordance with the active ingredients that are found in hash oil could possibly be important for dealing with cancer.